195 related articles for article (PubMed ID: 28355568)
21. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
22. Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.
Fu J; Koul D; Yao J; Wang S; Yuan Y; Colman H; Sulman EP; Lang FF; Yung WK
Cancer Res; 2013 May; 73(10):3062-74. PubMed ID: 23492364
[TBL] [Abstract][Full Text] [Related]
23. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
[TBL] [Abstract][Full Text] [Related]
24. GSK3 beta N-terminus binding to p53 promotes its acetylation.
Eom TY; Jope RS
Mol Cancer; 2009 Mar; 8():14. PubMed ID: 19265551
[TBL] [Abstract][Full Text] [Related]
25. WNT signaling suppresses oligodendrogenesis via Ngn2-dependent direct inhibition of Olig2 expression.
Jiang M; Yu D; Xie B; Huang H; Lu W; Qiu M; Dai ZM
Mol Brain; 2020 Nov; 13(1):155. PubMed ID: 33187539
[TBL] [Abstract][Full Text] [Related]
26. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
McKendrick L; Meek DW
Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
[TBL] [Abstract][Full Text] [Related]
27. Induced expression of nucleolin phosphorylation-deficient mutant confers dominant-negative effect on cell proliferation.
Xiao S; Caglar E; Maldonado P; Das D; Nadeem Z; Chi A; Trinité B; Li X; Saxena A
PLoS One; 2014; 9(10):e109858. PubMed ID: 25313645
[TBL] [Abstract][Full Text] [Related]
28. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.
Blaydes JP; Hupp TR
Oncogene; 1998 Aug; 17(8):1045-52. PubMed ID: 9747884
[TBL] [Abstract][Full Text] [Related]
29. Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification.
Mokhtari K; Paris S; Aguirre-Cruz L; Privat N; Crinière E; Marie Y; Hauw JJ; Kujas M; Rowitch D; Hoang-Xuan K; Delattre JY; Sanson M
Neuropathol Appl Neurobiol; 2005 Feb; 31(1):62-9. PubMed ID: 15634232
[TBL] [Abstract][Full Text] [Related]
30. Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.
Hergovich A; Lisztwan J; Thoma CR; Wirbelauer C; Barry RE; Krek W
Mol Cell Biol; 2006 Aug; 26(15):5784-96. PubMed ID: 16847331
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of neurofilament heavy-chain side-arm fragments by cyclin-dependent kinase-5 and glycogen synthase kinase-3alpha in transfected cells.
Bajaj NP; Miller CC
J Neurochem; 1997 Aug; 69(2):737-43. PubMed ID: 9231734
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a differential modulation of p53-phosphorylating kinases by the cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Neise D; Sohn D; Budach W; Jänicke RU
Cell Cycle; 2010 Sep; 9(17):3575-83. PubMed ID: 20818156
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
McKendrick L; Milne D; Meek D
Mol Cell Biochem; 1999 Jan; 191(1-2):187-99. PubMed ID: 10094408
[TBL] [Abstract][Full Text] [Related]
34. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
35. CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake.
Pastori V; Sangalli E; Coccetti P; Pozzi C; Nonnis S; Tedeschi G; Fusi P
Biochim Biophys Acta; 2010; 1802(7-8):583-92. PubMed ID: 20347968
[TBL] [Abstract][Full Text] [Related]
36. Pten loss in Olig2 expressing neural progenitor cells and oligodendrocytes leads to interneuron dysplasia and leukodystrophy.
Maire CL; Ramkissoon S; Hayashi M; Haidar S; Ramkissoon L; DiTomaso E; Ligon KL
Stem Cells; 2014 Jan; 32(1):313-26. PubMed ID: 24395742
[TBL] [Abstract][Full Text] [Related]
37. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
[TBL] [Abstract][Full Text] [Related]
38. A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.
Griveau A; Seano G; Shelton SJ; Kupp R; Jahangiri A; Obernier K; Krishnan S; Lindberg OR; Yuen TJ; Tien AC; Sabo JK; Wang N; Chen I; Kloepper J; Larrouquere L; Ghosh M; Tirosh I; Huillard E; Alvarez-Buylla A; Oldham MC; Persson AI; Weiss WA; Batchelor TT; Stemmer-Rachamimov A; Suvà ML; Phillips JJ; Aghi MK; Mehta S; Jain RK; Rowitch DH
Cancer Cell; 2018 May; 33(5):874-889.e7. PubMed ID: 29681511
[TBL] [Abstract][Full Text] [Related]
39. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
[TBL] [Abstract][Full Text] [Related]
40. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
